Wealth Science Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$808K Sell
3,090
-130
-4% -$33.3K 0.34% 39
2026
Q2
$810K Buy
3,220
+523
+19% +$113K 0.36% 44
2026
Q1
$616K Hold
2,697
– – 0.35% 30
2025
Q4
$616K Hold
2,697
– – 0.36% 30

Other funds holding ABBV

Wealth Science Advisors's ABBV Position: Q3 2026 in Review

Wealth Science Advisors reduced its AbbVie (ABBV) stake by 4% in Q3 2026, selling an estimated $33.3K and leaving 3,090 shares worth $808K. The position accounts for 0.34% of the portfolio, ranked #39.

Wealth Science Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $810K in Q2 2026. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Wealth Science Advisors held 3,090 shares of AbbVie worth $808K as of Q3 2026.
  • Wealth Science Advisors sold 130 AbbVie shares in Q3 2026, an estimated $33.3K.
  • AbbVie made up 0.34% of Wealth Science Advisors's portfolio in Q3 2026, its #39 holding.
  • Wealth Science Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Wealth Science Advisors's AbbVie position peaked at $810K in Q2 2026.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Wealth Science Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.